Feline hyperthyroidism: advances towards novel molecular therapeutics

Blackwood, L. and Argyle, D.J. (2002) Feline hyperthyroidism: advances towards novel molecular therapeutics. Journal of Small Animal Practice, 43, pp. 58-66. (doi: 10.1111/j.1748-5827.2002.tb00030.x)

Full text not currently available from Enlighten.


Feline hyperthyroidism is the most common endocrine disorder of the elderly cat. Traditionally, the disease is treated by surgical thyroidectomy, medical management with antithyroid drugs or radiation therapy using iodine-131. However, none of these treatments is ideal and molecular therapeutics may offer novel methods of treating the disease. This article reviews the background of, and preliminary investigations into, the development of a transcriptionally targeted somatic gene therapy strategy for the treatment of this feline condition.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Blackwood, Professor Laura
Authors: Blackwood, L., and Argyle, D.J.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Journal of Small Animal Practice
Publisher:Wiley-Blackwell Publishing Ltd.
ISSN (Online):1748-5827

University Staff: Request a correction | Enlighten Editors: Update this record